NRC Health Share-based Payment Arrangement, Expense, after Tax
NRC Health (NRC) reported Share-based Payment Arrangement, Expense, after Tax of $3.03 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2026-03-05
- NRC Health share-based payment arrangement, expense, after tax for fiscal 2025 was $3.03M, a 18837.50% increase from fiscal 2024.
- NRC Health share-based payment arrangement, expense, after tax for fiscal 2024 was $16.00K, a 94.97% decline from fiscal 2023.
- NRC Health share-based payment arrangement, expense, after tax for fiscal 2023 was $318.00K, a 58.38% decline from fiscal 2022.
- NRC Health share-based payment arrangement, expense, after tax for fiscal 2022 was $764.00K.
| Period end | Share-based Payment Arrangement, Expense, after Tax 12 month | Share-based Payment Arrangement, Expense, after Tax 12 month as first filed |
|---|---|---|
| 2025-12-31 | $3.03M 10-K · filed 2026-03-05 | |
| 2024-12-31 | $16.00K 10-K · filed 2026-03-05 | |
| 2023-12-31 | $318.00K 10-K · filed 2026-03-05 | |
| 2022-12-31 | $764.00K 10-K · filed 2025-03-17 | |
| 2021-12-31 | -$296.00K 10-K · filed 2024-02-27 | |
| 2020-12-31 | -$6.08M 10-K · filed 2023-03-03 | |
| 2019-12-31 | -$857.00K 10-K · filed 2022-03-04 | |
| 2018-12-31 | -$2.05M 10-K · filed 2021-03-05 | |
| 2017-12-31 | -$465.00K 10-K · filed 2020-03-06 | |
| 2016-12-31 | $765.00K 10-K · filed 2019-03-08 | $1.23M 10-K · filed 2017-03-03 |
| 2015-12-31 | $878.00K 10-K · filed 2018-03-14 | |
| 2014-12-31 | $473.00K 10-K · filed 2017-03-03 | |
| 2013-12-31 | $578.00K 10-K · filed 2016-03-04 | |
| 2012-12-31 | $235.00K 10-K · filed 2015-03-04 | |
| 2011-12-31 | $461.00K 10-K · filed 2014-03-04 | |
| 2010-12-31 | $470.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |